Having trouble accessing articles? Reset your cache.

FDA approves Oleptro

FDA approved an NDA from Labopharm Inc. (TSX:DDS; NASDAQ:DDSS) for Oleptro trazodone extended-release

Read the full 133 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE